Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/82100
Author(s): Nuno Vale
Miguel Prudencio
Catarina A Marques
Margaret S Collins
Jiri Gut
Fatima Nogueira
Joana Matos
Philip J Rosenthal
Melanie T Cushion
Virgilio E do Rosario
Maria M Mota
Rui Moreira
Paula Gomes
Title: Imidazoquines as Antimalarial and Antipneumocystis Agents
Issue Date: 2009
Abstract: Peptidomimetic imidazolidin-4-one derivatives of primaquine (imidazoquines) recently displayed in vitro activity against blood schizonts of a chloroquine-resistant strain of Plasmodium falciparum. Preliminary studies with a subset of such imidazoquines showed them to both block transmission of P. berghei malaria front mouse to mosquito and be highly stable toward hydrolysis at physiological conditions. This prompted Lis to have deeper insight into the activity of imidazoquines against both Plasmodia and Pneumocystis carinii, on which primaquine is also active. Full assessment of the in vivo transmission-blocking activity of imidazoquines, in vitro tissue-schizontocidal activity on P. berghei-infected hepatocytes, and in vitro anti-P. carinii activity is now reported. All compounds were active in these biological assays, with generally lower activity than the parent drug. However, imidazoquines' stability against both oxidative deamination and proteolytic degradation suggest that they will probably have higher oral bioavailability and lower hematotoxicity than primaquine, which might translate into higher therapeutic indexes.
Subject: Medicina básica
Basic medicine
Scientific areas: Ciências médicas e da saúde::Medicina básica
Medical and Health sciences::Basic medicine
URI: https://repositorio-aberto.up.pt/handle/10216/82100
Document Type: Artigo em Revista Científica Internacional
Rights: openAccess
License: https://creativecommons.org/licenses/by-nc/4.0/
Appears in Collections:FCUP - Artigo em Revista Científica Internacional

Files in This Item:
File Description SizeFormat 
89182.pdf1.18 MBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons